Libourne – 18 September 2018 – Fermentalg (Euronext – FALG), a French market leader in microalgae for nutrition and health, announced today the signing of an important agreement with DSM Nutritional Products in the field of high potency DHA products.
Under the terms of this 5 year agreement, Fermentalg and DSM will work together to develop and market high potency DHA products based on Fermentalg's ORIGINS DHA-550® product line.
“This is groundbreaking news for Fermentalg”, says Philippe Lavielle, Fermentalg's CEO; “An agreement with the uncontested world leader in nutritional lipids clearly confirms the capability of Fermentalg's DHA platform. It will accelerate the penetration of ORIGINS DHA-550® into the dynamic and fast-growing high potency DHA omega-3 market, with the potential of elevating Fermentalg to the top tier of the world's largest algal DHA producers.”
As part of this agreement, Fermentalg granted exclusivity to DSM for selling the products in certain market segments. Furthermore, the company will continue promoting its ORIGINS DHA® product range through its established network of distributors in the USA and in Europe, notably in the growing markets of functional foods and nutritional supplements for brain, vision and cardiovascular health.
An expert in research and bio-industrial use of microalgae, Fermentalg seeks to provide sustainable solutions and innovative products that contribute towards the creation of natural, healthy and effective products. Our business: the development, production and sale of active ingredients extracted from microalgae for the health and nutrition sectors. Natural nutritional oils, pigments and antioxidants, as well as specialty proteins, comprise our present and future offering.
Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG).
For more information, visit: www.fermentalg.com